Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Buy
56
ITGR Quote, Financials, Valuation and Earnings
Last price:
$121.72
Seasonality move
:
-0.23%
Day range:
$119.02 - $121.67
52-week range:
$104.93 - $146.36
Dividend yield:
0%
P/E ratio:
57.56x
P/S ratio:
2.45x
P/B ratio:
2.64x
Volume:
403.2K
Avg. volume:
731.2K
1-year change:
0.44%
Market cap:
$4.2B
Revenue:
$1.7B
EPS (TTM):
$2.11
Analysts' Opinion
-
Consensus RatingInteger Holdings has received a consensus rating of Buy. The company's average rating is a Buy based on 6 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $147.88, Integer Holdings has an estimated upside of 21.76% from its current price of $121.45.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $133.00 representing 100% downside risk from its current price of $121.45.
Fair Value
-
According to the consensus of 8 analysts, Integer Holdings has 21.76% upside to fair value with a price target of $147.88 per share.
ITGR vs. S&P 500
-
Over the past 5 trading days, Integer Holdings has underperformed the S&P 500 by -0.58% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Integer Holdings does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Integer Holdings has grown year-over-year revenues for 16 quarters straight. In the most recent quarter Integer Holdings reported revenues of $437.4M.
Earnings Growth
-
Integer Holdings has grown year-over-year earnings for 8 quarters straight. In the most recent quarter Integer Holdings reported earnings per share of -$0.66.
Enterprise value:
5.4B
EV / Invested capital:
1.91x
Price / LTM sales:
2.45x
EV / EBIT:
33.46x
EV / Revenue:
3.10x
PEG ratio (5yr expected):
1.45x
EV / Free cash flow:
48.80x
Price / Operating cash flow:
38.54x
Enterprise value / EBITDA:
19.62x
Gross Profit (TTM):
$473.1M
Return On Assets:
2.44%
Net Income Margin (TTM):
4.38%
Return On Equity:
4.85%
Return On Invested Capital:
2.85%
Operating Margin:
12.76%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1.4B | $1.6B | $1.8B | $407.8M | $437.4M | |
| Gross Profit | $361M | $428.6M | $473.1M | $108.3M | $120.3M | |
| Operating Income | $137.8M | $190M | $228.8M | $47.4M | $55.8M | |
| EBITDA | $208.3M | $269.2M | $277.3M | $64.1M | $29.8M | |
| Diluted EPS | $2.03 | $2.89 | $2.11 | $0.59 | -$0.66 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $409.2M | $494.8M | $629M | $668.6M | $702.2M | |
| Total Assets | $2.3B | $2.6B | $2.9B | $3.1B | $3.3B | |
| Current Liabilities | $161.6M | $173.1M | $225.5M | $201.4M | $206.4M | |
| Total Liabilities | $1.1B | $1.2B | $1.5B | $1.6B | $1.7B | |
| Total Equity | $1.3B | $1.4B | $1.4B | $1.5B | $1.6B | |
| Total Debt | $687.1M | $829.6M | $1B | $1.1B | $1.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $104.4M | $197.3M | $213.2M | $23.2M | $31.3M | |
| Cash From Investing | -$214.7M | -$306.9M | -$224.4M | -$168.2M | -$197.2M | |
| Cash From Financing | $126.6M | $112.2M | $1.6M | $163.3M | $151.6M | |
| Free Cash Flow | $15.8M | $72.9M | $111.5M | -$5.8M | $6.1M | |
ITGR
Sector
Market Cap
$4.2B
$34.2M
Price % of 52-Week High
82.98%
43.73%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.66%
1-Year Price Total Return
0.44%
-41.71%
Beta (5-Year)
1.030
0.657
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$120.10
200-day SMA
Sell
Level
$128.05
Bollinger Bands (100)
Sell
Level
117.22 - 137.22
Chaikin Money Flow
Buy
Level
26.4M
20-day SMA
Buy
Level
$121.26
Relative Strength Index (RSI14)
Buy
Level
52.84
ADX Line
Sell
Level
14.99
Williams %R
Neutral
Level
-50.2691
50-day SMA
Buy
Level
$118.79
MACD (12, 26)
Buy
Level
0.19
25-day Aroon Oscillator
Buy
Level
24
On Balance Volume
Neutral
Level
30.9M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.179)
Buy
CA Score
(Annual)
Level (0.1554)
Buy
Beneish M-Score
(Annual)
Level (-2.5609)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-0.678)
Buy
Piotroski F Score
(Annual)
Level (9)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.
Stock Forecast FAQ
In the current month, ITGR has received 6 Buy ratings 2 Hold ratings, and 0 Sell ratings. The ITGR average analyst price target in the past 3 months is $147.88.
-
Where Will Integer Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Integer Holdings share price will rise to $147.88 per share over the next 12 months.
-
What Do Analysts Say About Integer Holdings?
Analysts are divided on their view about Integer Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Integer Holdings is a Sell and believe this share price will drop from its current level to $133.00.
-
What Is Integer Holdings's Price Target?
The price target for Integer Holdings over the next 1-year time period is forecast to be $147.88 according to 8 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is ITGR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Integer Holdings is a Buy. 6 of 8 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ITGR?
You can purchase shares of Integer Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Integer Holdings shares.
-
What Is The Integer Holdings Share Price Today?
Integer Holdings was last trading at $121.72 per share. This represents the most recent stock quote for Integer Holdings. Yesterday, Integer Holdings closed at $121.45 per share.
-
How To Buy Integer Holdings Stock Online?
In order to purchase Integer Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Mobileye Might Be Wall Street’s Next Big Surprise
The trend to automate vehicles started long ago when adding…
Why Is Rigetti Stock Going Up?
Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
99
SOC alert for May 20
Sable Offshore [SOC] is up 2.39% over the past day.
Buy
52
RGC alert for May 20
Regencell Bioscience Holdings [RGC] is up 21.12% over the past day.
Sell
40
GWLIF alert for May 20
Great-West Lifeco [GWLIF] is up 12.44% over the past day.
